X4 Pharmaceuticals Inc.
XFOR | NASDAQ
$3.43
-$0.06 (-1.86%)
Sep 22, 2026, 1:49 PM ET · Market open
TTM Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | -110.38M | -99.72M | -79.2M | -95.1M | -101.98M | 14.6M | -37.45M | -16.76M | 17.63M | -128.91M | -101.17M | -111.14M | -130.42M | -95.92M | -93.87M | -94.97M | -93.56M | -91.99M | -88.7M | -76.89M | -74.16M | -69.67M |
Depreciation & Amortization | 1.9M | 1.04M | 1.28M | 1.33M | 1.38M | 1.22M | 809K | 598K | 820K | 1.14M | 1.59M | 2.03M | 2.02M | 2.01M | 1.99M | 1.99M | 1.98M | 1.97M | 1.89M | 1.79M | 1.72M | 1.46M |
Stock-Based Compensation | 8.53M | 3.78M | 4.3M | 4.24M | 3.48M | 2.74M | 2.22M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Working Capital | -325K | 6.52M | 1.57M | -1.9M | -5.23M | -3.18M | 4.95M | -2.71M | -1.79M | -1.13M | -890K | 6.85M | 6.29M | 4.23M | 2.31M | -2.45M | 1.41M | -551K | -2.66M | -1.67M | -5.09M | -2.05M |
Other Non-Cash Items | 5.27M | 3.77M | -9.42M | -6.66M | -4.24M | -125.53M | -99.15M | -105.61M | -132.22M | 22.36M | 2.72M | 10.08M | 34.56M | 3.88M | 9.04M | 16.99M | 17.04M | 17.4M | 17.4M | 7.2M | 7.42M | 6.72M |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | -8.66M | -1.71M | -2.58M | -6.9M | -7.95M | -2.7M | 2.67M | -3.88M | 1.32M | 1.82M | 344K | 11.18M | 7.51M | 6.65M | 5.74M | -1.07M | 2.57M | -75K | -1.5M | -1.45M | -4.44M | -239K |
Operating Cash Flow | -103.34M | -92.85M | -85.62M | -103.09M | -109.3M | -109.67M | -130.9M | -125.65M | -112.45M | -103.6M | -96.51M | -87.86M | -86.34M | -83.39M | -77.1M | -77.06M | -71.97M | -72.69M | -70.91M | -69.36M | -69.47M | -61.74M |
Capital Expenditures | 19.6M | 19.6M | -3M | -3.04M | -3.13M | -3.27M | -326K | -320K | -236K | -110K | -60K | -59K | -60K | -90K | -103K | -82K | -93K | -141K | -615K | -904K | -1.38M | -1.3M |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -46.44M | -51.5M | -63.39M | -84.27M | -60.82M | -58.76M | -57.13M | -40.15M | -25.21M | -27.09M | -16.82M | -11.03M | -4.88M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | 77.12M | 82.04M | 74.54M | 69.99M | 59.38M | 33.2M | 26.45M | 13.25M | 9M | 7M | 2M | 1M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | -5M | n/a | n/a | n/a | n/a | 98M | 98M | 98M | 98M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | 25.68M | 30.54M | 8.15M | -17.32M | -4.58M | 69.17M | 66.99M | 70.78M | 81.55M | -20.2M | -14.88M | -10.08M | -4.94M | -90K | -103K | -82K | -93K | -141K | -615K | -904K | -1.38M | -1.3M |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | 20M | 20M | 20M | 41.74M | 21.74M | 20.44M | 20.44M | -861K | -1.19M | -795K | -795K | -1.23M | -909K | n/a | 7.5M | 7.5M | 7.5M |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 443K | n/a | n/a | n/a | -443K | n/a | -2M | -2M | -2M | -2M | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 52K | 52K | 52K | 248K | 294K | 294K | 294K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -12K | 1.99M | -12K | -12K | n/a | -2M | -264K | -278K |
Financial Cash Flow | 233.08M | 238.63M | 238.63M | 92.67M | 5.77M | 20.29M | 20.29M | 20.26M | 41.46M | 90.64M | 88.52M | 149.06M | 179.84M | 110.15M | 117.23M | 81.16M | 24.74M | 24.16M | 74.25M | 57.3M | 61.46M | 62.45M |
Net Cash Flow | 154.8M | 175.85M | 161.36M | -27.78M | -108M | -20.24M | -43.78M | -34.42M | 10.54M | -33.16M | -22.54M | 51.98M | 89.3M | 27.23M | 40.22M | 3.46M | -47.78M | -48.52M | 2.82M | -12.42M | -8.58M | -109K |
Free Cash Flow | -83.74M | -73.25M | -88.62M | -106.13M | -112.43M | -112.94M | -131.23M | -125.97M | -112.69M | -103.71M | -96.57M | -87.92M | -86.4M | -83.48M | -77.21M | -77.14M | -72.06M | -72.83M | -71.52M | -70.26M | -70.85M | -63.04M |
Adj. Free Cash Flow | -92.27M | -77.03M | -92.92M | -110.37M | -115.91M | -115.68M | -133.44M | -125.97M | -112.69M | -103.71M | -96.57M | -87.92M | -86.4M | -83.48M | -77.21M | -77.14M | -72.06M | -72.83M | -71.52M | -70.26M | -70.85M | -63.04M |
Maintenance CapEx | -236K | -236K | n/a | n/a | n/a | n/a | -59K | -94K | -102K | -110K | -60K | -59K | -60K | -90K | -103K | -82K | -93K | -141K | -615K | -904K | -1.38M | -1.3M |
Growth CapEx | 19.84M | 19.84M | -3M | -3.04M | -3.13M | -3.27M | -267K | -226K | -134K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Owner Earnings | -103.57M | -93.09M | -85.62M | -103.09M | -109.3M | -109.67M | -130.96M | -125.75M | -112.55M | -103.71M | -96.57M | -87.92M | -86.4M | -83.48M | -77.21M | -77.14M | -72.06M | -72.83M | -71.52M | -70.26M | -70.85M | -63.04M |
Add to Watchlist
Select watchlists to add or remove XFOR